- The role of dialogue between government, the pharmaceutical industry, the medical community and patients inshaping medicines policy
- How do we ensure wider access to cheaper medicines while simultaneously supporting innovation?
- Challenges related to medicines pricing, free medicine programmes and reimbursement changes